Revolutions in treatment options in gastrointestinal stromal tumours (GISTs): the latest updates: Revolutions in treatment options in GIST

The treatment of advanced GIST is rapidly evolving with the development of novel molecular compounds such as avapritinib and ripretinib, but also promising results have been achieved with cabozantinib in a phase II trial. The availability of over five lines of treatment for patients with advanced GI...

Descripción completa

Detalles Bibliográficos
Autores principales: Farag, Sheima, Smith, Myles J., Fotiadis, Nicos, Constantinidou, Anastasia, Jones, Robin L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Sarcoma (SH Okuno, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253383/
https://www.ncbi.nlm.nih.gov/pubmed/32462367
http://dx.doi.org/10.1007/s11864-020-00754-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253383/
https://www.ncbi.nlm.nih.gov/pubmed/32462367
http://dx.doi.org/10.1007/s11864-020-00754-8

Ejemplares similares